- Home
- IVVD vs SRTS Comparison
IVVD vs SRTS Comparison
Compare IVVD & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- SRTS
- Stock Information
- Founded
- IVVD 2020
- SRTS 2010
- Country
- IVVD United States
- SRTS United States
- Employees
- IVVD N/A
- SRTS N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- IVVD Health Care
- SRTS Health Care
- Exchange
- IVVD Nasdaq
- SRTS Nasdaq
- Market Cap
- IVVD 116.8M
- SRTS 106.0M
- IPO Year
- IVVD 2021
- SRTS 2016
- Fundamental
- Price
- IVVD $0.44
- SRTS $7.10
- Analyst Decision
- IVVD Strong Buy
- SRTS Strong Buy
- Analyst Count
- IVVD 4
- SRTS 2
- Target Price
- IVVD $7.89
- SRTS $12.50
- AVG Volume (30 Days)
- IVVD 981.7K
- SRTS 190.3K
- Earning Date
- IVVD 11-14-2024
- SRTS 02-06-2025
- Dividend Yield
- IVVD N/A
- SRTS N/A
- EPS Growth
- IVVD N/A
- SRTS N/A
- EPS
- IVVD N/A
- SRTS 0.57
- Revenue
- IVVD $11,564,000.00
- SRTS $41,308,000.00
- Revenue This Year
- IVVD N/A
- SRTS $65.04
- Revenue Next Year
- IVVD $486.65
- SRTS $24.87
- P/E Ratio
- IVVD N/A
- SRTS $12.48
- Revenue Growth
- IVVD N/A
- SRTS 65.62
- 52 Week Low
- IVVD $0.40
- SRTS $2.15
- 52 Week High
- IVVD $5.20
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- IVVD 29.58
- SRTS 32.61
- Support Level
- IVVD $0.57
- SRTS $8.30
- Resistance Level
- IVVD $0.51
- SRTS $9.07
- Average True Range (ATR)
- IVVD 0.06
- SRTS 0.43
- MACD
- IVVD -0.01
- SRTS -0.25
- Stochastic Oscillator
- IVVD 13.30
- SRTS 1.78
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.